© CNRS Images / Inserm - 2013
Reference
4045
Parkinson's Disease
The Institute for Neurodegenerative Diseases (IMN) in Bordeaux (France) combines basic research, preclinical and clinical research in the context of neurodegenerative diseases, particularly in Parkinson's disease. This disease, whose origin is not known, affects 150,000 people in France. Researchers of this institute explain its mechanism and treatments that exist as the drug L-Dopa.
They offer a solution for deep brain surgery simulation currently practiced in the Pellegrin Hospital. This was developed in 1993 by Dr. Christian Gross, DR. Abdelhamid Benazzouz and Dr. Bernard Bioulac.
Duration
Production year
Définition
Color
Sound
Version(s)
Original material
The use of media visible on the CNRS Images Platform can be granted on request. Any reproduction or representation is forbidden without prior authorization from CNRS Images (except for resources under Creative Commons license).
No modification of an image may be made without the prior consent of CNRS Images.
No use of an image for advertising purposes or distribution to a third party may be made without the prior agreement of CNRS Images.
For more information, please consult our general conditions